ENANTA PHARMACEUTICALS INC Annual Operating Lease, Payments in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Enanta Pharmaceuticals Inc annual/quarterly Operating Lease, Payments history and growth rate from 2020 to 2023.
  • Enanta Pharmaceuticals Inc Operating Lease, Payments for the quarter ending May 12, 2022 was $76.5K.
  • Enanta Pharmaceuticals Inc annual Operating Lease, Payments for 2023 was $4.59M, a 7.53% decline from 2022.
  • Enanta Pharmaceuticals Inc annual Operating Lease, Payments for 2022 was $4.97M, a 22% decline from 2021.
  • Enanta Pharmaceuticals Inc annual Operating Lease, Payments for 2021 was $6.36M, a 54.2% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.59M -$374K -7.53% Oct 1, 2022 Sep 30, 2023 10-K 2023-11-22
2022 $4.97M -$1.4M -22% Oct 1, 2021 Sep 30, 2022 10-K 2023-11-22
2021 $6.36M +$2.24M +54.2% Oct 1, 2020 Sep 30, 2021 10-K 2023-11-22
2020 $4.13M Oct 1, 2019 Sep 30, 2020 10-K 2021-11-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.